All Stories

  1. Patient preferences for asthma management: a qualitative study

    Article • BMJ Open, August 2020, BMJ

    James Fingleton

  2. What matters most to patients when choosing treatment for mild–moderate asthma? Results from a discrete choice experiment

    Article • Thorax, July 2020, BMJ

    James Fingleton

  3. Self-titration of inhaled corticosteroid and β2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial

    Article • European Respiratory Journal, May 2020, European Respiratory Society (ERS)

    James Fingleton

  4. Pre-apneic capnography waveform abnormalities during procedural sedation and analgesia

    Article • Journal of Clinical Monitoring and Computing, September 2019, Springer Science + Business Media

    James Fingleton

  5. Which traits to target in asthma? Importance of treatable traits varies depending on desired outcome

    Article • September 2019, European Respiratory Society (ERS)

    James Fingleton

  6. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial

    Article • The Lancet, September 2019, Elsevier

    James Fingleton

  7. Nasal gene expression changes with inhaled corticosteroid treatment in asthma

    Article • Allergy, July 2019, Wiley

    James Fingleton

  8. Sequence analysis of capnography waveform abnormalities during nurse-administered procedural sedation and analgesia in the cardiac catheterization laboratory

    Article • Scientific Reports, July 2019, Springer Science + Business Media

    James Fingleton

  9. Protocol for a randomised, single-blind, two-arm, parallel-group controlled trial of the efficacy of rhinothermy delivered by nasal high flow therapy in the treatment of the common cold

    Article • BMJ Open, June 2019, BMJ

    James Fingleton

  10. Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma

    Article • New England Journal of Medicine, May 2019, New England Journal of Medicine (NEJM/MMS)

    James Fingleton

  11. Nasal high‐flow therapy compared with non‐invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross‐over trial

    Article • Respirology, May 2019, Wiley

    James Fingleton

  12. Severe Asthma Global Evaluation (SAGE): An Electronic Platform for Severe Asthma

    Article • The Journal of Allergy and Clinical Immunology In Practice, May 2019, Elsevier

    James Fingleton

  13. Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report

    Article • European Respiratory Journal, March 2019, European Respiratory Society (ERS)

    vanessa mcdonald, James Fingleton, Conjoint Professor Peter Wark

  14. Serum periostin levels in adults of Chinese descent: an observational study

    Article • Allergy Asthma & Clinical Immunology, December 2018, Springer Science + Business Media

    James Fingleton

  15. Type 2 Biomarkers and Prediction of Future Exacerbations and Lung Function Decline in Adult Asthma

    Article • The Journal of Allergy and Clinical Immunology In Practice, November 2018, Elsevier

    James Fingleton

  16. Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial

    Article • BMC Pulmonary Medicine, October 2018, Springer Science + Business Media

    James Fingleton

  17. Accuracy and precision of transcutaneous carbon dioxide monitoring: a systematic review and meta-analysis

    Article • Thorax, September 2018, BMJ

    James Fingleton

  18. Serum periostin levels following small bone fractures, long bone fractures and joint replacements: an observational study

    Article • Allergy Asthma & Clinical Immunology, July 2018, Springer Science + Business Media

    James Fingleton

  19. Change in biomarkers of type-2 inflammation following severe exacerbations of asthma

    Article • Thorax, July 2018, BMJ

    James Fingleton

  20. Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial

    Article • July 2018, Springer Science + Business Media

    James Fingleton

  21. Randomised controlled trial of rhinothermy for treatment of the common cold: a feasibility study

    Article • BMJ Open, March 2018, BMJ

    James Fingleton

  22. The inhaled corticosteroid/long-acting β-agonist maintenance and reliever therapy regimen: where to from here?

    Article • European Respiratory Journal, January 2018, European Respiratory Society (ERS)

    James Fingleton, James Harper

  23. Treatable traits of chronic airways disease

    Article • Current Opinion in Pulmonary Medicine, January 2018, Wolters Kluwer Health

    James Fingleton

  24. Phenotypes of symptomatic airways disease in China and New Zealand

    Article • European Respiratory Journal, December 2017, European Respiratory Society (ERS)

    James Fingleton

  25. Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trial

    Article • Respirology, September 2017, Wiley

    Dr Irene E Braithwaite, James Fingleton, James Harper

  26. Late Breaking Abstract - The duration of anti-inflammatory action of fluticasone furoate (FF) assessed via exhaled nitric oxide (FeNO) in asthmatics following administration of FF/vilanterol (VI)

    Article • September 2017, European Respiratory Society (ERS)

    James Fingleton

  27. Oxygen compared to air driven nebulisers for acute exacerbations of COPD: a randomised controlled trial

    Article • September 2017, European Respiratory Society (ERS)

    James Fingleton

  28. Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma

    Article • BMJ Open Respiratory Research, July 2017, BMJ

    James Fingleton

  29. Longitudinal variation of serum periostin levels in adults with stable asthma

    Article • Journal of Allergy and Clinical Immunology, May 2017, Elsevier

    James Fingleton

  30. RCT of the effect of berryfruit polyphenolic cultivar extract in mild steroid-naive asthma: a cross-over, placebo-controlled study

    Article • BMJ Open, March 2017, BMJ

    James Fingleton

  31. Day-time variation of serum periostin in asthmatic adults treated with ICS/LABA and adults without asthma

    Article • Allergy Asthma & Clinical Immunology, February 2017, Springer Science + Business Media

    James Fingleton

  32. Reference ranges for serum periostin in a population without asthma or chronic obstructive pulmonary disease

    Article • Clinical & Experimental Allergy, June 2016, Wiley

    James Fingleton, James Harper

  33. Serum periostin in obstructive airways disease

    Article • European Respiratory Journal, February 2016, European Respiratory Society (ERS)

    James Fingleton

  34. Randomised controlled trial of topical kanuka honey for the treatment of acne

    Article • BMJ Open, January 2016, BMJ

    James Fingleton

  35. Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults

    Article • Journal of Allergy and Clinical Immunology, September 2015, Elsevier

    James Fingleton

  36. A single-blind randomised controlled trial of topical kanuka honey for the treatment of nappy rash

    Article • Focus on Alternative and Complementary Therapies, August 2015, Wiley

    James Fingleton

  37. Randomised controlled trial of topical kanuka honey for the treatment of rosacea

    Article • BMJ Open, June 2015, BMJ

    James Fingleton

  38. Randomised controlled trial of topical kanuka honey for the treatment of cold sores

    Article • Advances in Integrative Medicine, December 2014, Elsevier

    James Fingleton

  39. S43 Real World Experience Of The Use Of Pet-ct For Distinguishing Between Benign Pleural Disease And Malignant Mesothelioma

    Article • Thorax, November 2014, BMJ

    James Fingleton

  40. A randomised controlled trial of topical Kanuka honey for the treatment of psoriasis

    Article • JRSM Open, March 2014, SAGE Publications

    James Fingleton

  41. A randomised controlled trial of topical Kanuka honey for the treatment of eczema

    Article • JRSM Open, January 2014, SAGE Publications

    James Fingleton

  42. Topical kanuka honey for the treatment of nappy rash

    Article • Focus on Alternative and Complementary Therapies, January 2014, Wiley

    James Fingleton

  43. Letter in response to Tashkinet al: limited generalisability of uplift findings to clinical practice

    Article • Thorax, November 2013, BMJ

    James Fingleton

  44. Topical kanuka honey for the treatment of rosacea

    Article • Focus on Alternative and Complementary Therapies, September 2013, Wiley

    James Fingleton

  45. Limited generalisability of UPLIFT findings to clinical practice: Table 1

    Article • Thorax, June 2013, BMJ

    James Fingleton

  46. Efficacy of Micromobile Foot Compression Device in Increasing Lower Limb Venous Blood Flow

    Article • International Journal of Vascular Medicine, January 2013, Hindawi Publishing Corporation

    James Fingleton

  47. A half doubling dose change in bronchial hyperresponsiveness in a population represents an important difference

    Article • Translational Respiratory Medicine, January 2013, Springer Science + Business Media

    James Fingleton

  48. Restriction of LABA use to combination ICS/LABA inhaler therapy in asthma

    Article • Thorax, November 2012, BMJ

    James Fingleton

  49. Bronchodilator responsiveness: interpret with caution

    Article • Thorax, June 2012, BMJ

    James Fingleton

  50. Proposed MHRA changes to UK children's paracetamol dosing recommendations: modelling study

    Article • Journal of the Royal Society of Medicine, May 2012, SAGE Publications

    James Fingleton

  51. Towards individualised medicine for airways disease: identifying clinical phenotype groups: Figure 1–

    Article • European Respiratory Journal, March 2012, European Respiratory Society (ERS)

    James Fingleton

  52. Individualized treatment for asthma

    Article • January 2012, Future Medicine

    James Fingleton

  53. British National Formulary for Children: the risk of inappropriate paracetamol prescribing

    Article • Archives of Disease in Childhood, October 2011, BMJ

    James Fingleton

  54. Towards individualised treatment in COPD

    Article • Thorax, January 2011, BMJ

    James Fingleton